Investing in Health Care: 3 Innovative New Drugs to Watch
Posted in Investments by Kevin | Tags: biotechnology, cancer, drug, drugs, health care, Investments, malarial drug, nanotechnology, novartis, pharmaceuticalsAccording to analysts, about 1 in 13 successful drugs is a “blockbuster.” Blockbuster drugs net over a billion in revenue and keep pharmaceutical companies profitable. Many new drugs can fail, get out-competed by other drugs, or never hit full stride, costing companies hundreds of millions of dollars lost to research, marketing, and approval.
Recently, I came across a few up and coming drugs and wanted to shed some light on whether investing in their respective manufacturing companies is a good idea or not.
1) Novartis- Malarial Drug – “spiroindolones”
Mergers & Acquisitions: The Next Accurate Economic Predictor?
Posted in Corporate by Kevin | Tags: acquisitions, Economy, investment strategies, Investments, Mergers, predictions, stock market, stocks, tipsSo, what’s the big deal about M & A’s anyway?
Mergers & Acquisitions have traditionally been linked to investor confidence in the market, directly leading to more money going into the stock market. M & A activity has been very low since the recession began as CEOs are unwilling to take big risks, instead holding on to cash assets.
So, let’s take a look at some previous cycles of M & A Activity and how they corresponded to the stock market:
Subscribe for E-mail Updates
Navigate
New on SmarterSpend
- 8 Companies Facing Bankruptcy in 2011
- The Ultimate Personal Finance Blog Rankings from MoneyCrashers!
- Investing in Health Care: 3 Innovative New Drugs to Watch
- Mergers & Acquisitions: The Next Accurate Economic Predictor?
- 5 Great Money Making Investments for Everyone